tumbled after the biotech company's fourth-quarter profit fell short of Wall Street's expectations. The stock was losing $2.46, or 12.3%, to $17.48.
On the other hand,
reported a fourth-quarter profit that exceeded expectations. The German drugmaker was recently up $1.15, or 2%, to $58.32.
rose 1.3% after
shareholders voted to approve the pending merger deal. CVS will acquire Caremark for $26.5 billion in cash and stock. CVS was also higher, adding 45 cents, or 1.4%, to $32.76.
, which had launched its own hostile bid for Caremark before getting rejected, was shedding 45 cents, or 0.6%, at $80.65.
was gaining 1.5% at $31.35.
Coventry Health Care
was tacking on 1.2% at $55.
Laboratory Corp. of America Holdings
was recently up 1.2% to $71.06.
was losing 2.5% at $50.86.
St. Jude Medical
was recently lower by 2.4% at $37.58.
was off 1% to $60.11.